Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer

This study has been completed.
Roche Pharma AG
Information provided by:
Swedish Medical Center Identifier:
First received: April 18, 2006
Last updated: March 4, 2010
Last verified: March 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)